Has Curtis Mack, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,736 in general payments to Curtis Mack, MD across 115 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Curtis Mack, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Curtis Mack, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Curtis Mack, MD

Radiation Oncology · Tucson, AZNPI 1568411890

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 46 manufacturers reported payments, led by Theragenics Corporation at 43.1% of the total. Reporting peaked in 2022 at $3,129 and has fallen 71.9% since, to $881 in 2025.

$7,736in general payments, 2019–2025

Across 115 payments — averaging $67.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Theragenics Corporation$3K
Varian Medical Systems, Inc.$1K
Progenics Pharmaceuticals, Inc.$250
Sumitomo Pharma America, Inc.$239
Medtronic$203
Regeneron Healthcare Solutions, Inc.$201
plus $2K from 40 others

What the payments were for

Consulting fees$2,63934%
Travel & lodging$75010%
Food & beverage$4,33156%
Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Theragenics Corporation	5	$3,334
Varian Medical Systems, Inc.	7	$1,039
Progenics Pharmaceuticals, Inc.	2	$250
Sumitomo Pharma America, Inc.	6	$239
Medtronic	1	$203
Regeneron Healthcare Solutions, Inc.	4	$201
AstraZeneca(2 entities)	10	$192
Siemens Medical Solutions USA, Inc.	2	$178
Seagen Inc.	3	$169
Merck	6	$150
Palette Life Sciences, Inc.	2	$147
Teleflex LLC	2	$143
Novartis	6	$142
Boston Scientific	6	$108
AbbVie	4	$100
Sanofi	3	$96
Genmab U.S., Inc.	3	$74
Incyte Corporation	4	$73
Pinnacle Biologics, Inc	1	$61
Genentech USA, Inc.	2	$61
GSK	3	$58
Amgen	3	$56
Johnson & Johnson	2	$49
Blueprint Medicines Corporation	2	$49
Abbott	1	$48
Ipsen Biopharmaceuticals, Inc	2	$48
Blue Earth Diagnostics	2	$39
Pfizer	2	$33
Pharmacosmos Therapeutics Inc.	1	$29
Jazz Pharmaceuticals Inc.	1	$29
Karyopharm Therapeutics Inc.	2	$27
Bayer	1	$26
AVEO Pharmaceuticals, Inc.	1	$24
Pharmacyclics LLC, An Abbvie Company	1	$23
Morphosys, US Inc.	1	$23
Sirtex Medical Inc	1	$23
Caris MPI, Inc.	1	$22
Beigene USA, Inc.	1	$21
Pharmaessentia USA Corporation	1	$20
Astellas Pharma US Inc	1	$20
Takeda Pharmaceuticals U.S.A., Inc.	1	$20
Deciphera Pharmaceuticals Inc.	1	$19
Novo Nordisk	1	$18
Adaptive Biotechnologies Corporation	1	$18
Genentech, Inc.	1	$17
Lilly USA, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,736 in reported general payments places this provider in the 80th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona →

Medicare billing

Part B allowed, 2024

$1,413,759

Medicare patients

368

Services billed

19,546

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	57	$406
Lorazepam	14	$43
Ciprofloxacin Hcl	13	$20
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$8

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Tucson

Baldassarre SteaTucson$10K
Robert GinTucson$9K
David VonkTucson$6K
Christopher MorrisonTucson$4K
Samuel DayTucson$3K
David FryeTucson$3K
Reginald WestmacottTucson$3K
Sarah KilicTucson$2K
John KreslPhoenix$248K
Eric GrossChandler$26K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →